This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy ) is assessing multiple possible treatments in patients hospitalised for COVID-19. We evaluated the use of a higher dose of corticosteroids in this patient group. Low-dose corticosteroids have been shown to reduce mortality for patients with COVID-19 requiring oxygen or ventilatory support (non-invasive mechanical ventilation, invasive mechanical ventilation, or extracorporeal membrane oxygenation).
0 Comments
Leave a Reply. |